Article ; Online: Oral and oropharyngeal malignant minor salivary gland tumors: a retrospective study.
Journal of stomatology, oral and maxillofacial surgery
2024 , Page(s) 101893
Abstract: Introduction: Tumors of minor salivary gland origin are uncommon lesions, representing 2-3% of all malignant neoplasms of the upper aerodigestive tract and 9-23% of all salivary gland tumors. The aim of this study is to report the demographic features, ... ...
| Abstract | Introduction: Tumors of minor salivary gland origin are uncommon lesions, representing 2-3% of all malignant neoplasms of the upper aerodigestive tract and 9-23% of all salivary gland tumors. The aim of this study is to report the demographic features, sites, histological types and the management and outcomes of oral and oropharyngeal minor salivary gland tumors diagnosed and treated in a University Hospital with a multidisciplinary head and neck team. Materials and methods: A single-center retrospective observational study was conducted in a cohort of patients who received diagnosis of minor salivary gland carcinoma of oropharynx and oral cavity between July 30th 2000 and 30th September 2021. The following data of the included patients were collected: age, gender, smoke history, alcohol consumption, past medical history, comorbidities, anatomic location of the tumor, histopathology, staging, management, and outcomes. Results: A total of 30 cases (16 females, 14 males) of oral and oropharyngeal minor salivary gland tumors were reviewed. The most frequent histotype was polymorphous adenocarcinoma (12 patients). The majority of patients presented with low stage at diagnosis, with 66,66% of the population classified as stage I or II at diagnosis. On the whole, 29 patients out of 30 benefitted from a surgical approach as first treatment. In 11 patients, adjuvant radiotherapy was performed and in 6 cases it was associated with chemotherapy. Brachytherapy with different timing was performed in 5 cases. The recurrence rate was 26.66%. Overall disease specific survival at five and ten years was found to be approximately 81% and 33% respectively. Conclusions: Surgery is still considered to be the gold standard of the treatment of minor salivary gland tumors. Radiation therapy, in spite of not being considered as a curative primary treatment for salivary malignancies, is extensively used as an adjuvant treatment. |
|---|---|
| Language | English |
| Publishing date | 2024-04-24 |
| Publishing country | France |
| Document type | Journal Article |
| ZDB-ID | 2916276-2 |
| ISSN | 2468-7855 ; 2468-8509 |
| ISSN (online) | 2468-7855 |
| ISSN | 2468-8509 |
| DOI | 10.1016/j.jormas.2024.101893 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.